OBJECTIVE: To determine trends in the incidence and clinical presentation of ankylosing spondylitis (AS), the incidence of cardiovascular disease (CVD), and cardiovascular (CV) risk factors among patients with AS and compare the observed incidence of CVD with that predicted by the Framingham Risk Score (FRS). METHODS: A population-based inception cohort of residents of Olmsted County, Minnesota age ≥18 years who fulfilled Modified New York Criteria for AS in 1980-2009 was assembled. Clinical features at presentation were recorded. Age- and sex-adjusted incidence rates and survival were estimated. Incident CVD and CV risk factors were identified. The 10-year CVD risk was calculated using the FRS. Standardized incidence ratios (ratios of observed CVD in AS to that predicted by the FRS) were calculated. RESULTS: Eighty-six patients were diagnosed with AS over the study period with an age- and sex-adjusted incidence of 3.1 per 100,000 (95% confidence interval [95% CI] 2.5-3.8). The mean age at diagnosis was 35 years (range 19-69 years). Inflammatory back pain, seen in 90% of patients, was the most common presenting manifestation. The 10-year mean ± SD cumulative incidence of CVD was 15.8% ± 6.1%, three times higher than the predicted events based on the FRS (standardized incidence ratio 3.01, 95% CI 1.35-6.69; P = 0.007). Overall survival was similar to the general population. CONCLUSION: AS occurs in approximately 3 persons per 100,000 per year. Clinical features, extraarticular manifestations, and interval from symptom onset to diagnosis have remained constant in this population over the study period. The CVD risk in these patients is higher than expected and underestimated by the FRS.
OBJECTIVE: To determine trends in the incidence and clinical presentation of ankylosing spondylitis (AS), the incidence of cardiovascular disease (CVD), and cardiovascular (CV) risk factors among patients with AS and compare the observed incidence of CVD with that predicted by the Framingham Risk Score (FRS). METHODS: A population-based inception cohort of residents of Olmsted County, Minnesota age ≥18 years who fulfilled Modified New York Criteria for AS in 1980-2009 was assembled. Clinical features at presentation were recorded. Age- and sex-adjusted incidence rates and survival were estimated. Incident CVD and CV risk factors were identified. The 10-year CVD risk was calculated using the FRS. Standardized incidence ratios (ratios of observed CVD in AS to that predicted by the FRS) were calculated. RESULTS: Eighty-six patients were diagnosed with AS over the study period with an age- and sex-adjusted incidence of 3.1 per 100,000 (95% confidence interval [95% CI] 2.5-3.8). The mean age at diagnosis was 35 years (range 19-69 years). Inflammatory back pain, seen in 90% of patients, was the most common presenting manifestation. The 10-year mean ± SD cumulative incidence of CVD was 15.8% ± 6.1%, three times higher than the predicted events based on the FRS (standardized incidence ratio 3.01, 95% CI 1.35-6.69; P = 0.007). Overall survival was similar to the general population. CONCLUSION: AS occurs in approximately 3 persons per 100,000 per year. Clinical features, extraarticular manifestations, and interval from symptom onset to diagnosis have remained constant in this population over the study period. The CVD risk in these patients is higher than expected and underestimated by the FRS.
Authors: M A Brown; L G Kennedy; A J MacGregor; C Darke; E Duncan; J L Shatford; A Taylor; A Calin; P Wordsworth Journal: Arthritis Rheum Date: 1997-10
Authors: Mayris P Webber; William Moir; Cynthia S Crowson; Hillel W Cohen; Rachel Zeig-Owens; Charles B Hall; Jessica Berman; Basit Qayyum; Nadia Jaber; Eric L Matteson; Yang Liu; Kerry Kelly; David J Prezant Journal: Mayo Clin Proc Date: 2015-12-09 Impact factor: 7.616
Authors: Haseeb Chaudhary; Nidrit Bohra; Khezar Syed; Anthony Donato; M Hassan Murad; Paras Karmacharya Journal: Arthritis Care Res (Hoboken) Date: 2021-11-17 Impact factor: 5.178
Authors: Marcos A González-López; Marina Lacalle; Cristina Mata; María López-Escobar; Alfonso Corrales; Raquel López-Mejías; Javier Rueda; M Carmen González-Vela; Miguel A González-Gay; Ricardo Blanco; José L Hernández Journal: PLoS One Date: 2018-01-04 Impact factor: 3.240
Authors: Javier Rueda-Gotor; Fernanda Genre; Alfonso Corrales; Ricardo Blanco; Patricia Fuentevilla; Virginia Portilla; Rosa Expósito; Cristina Mata; Trinitario Pina; Carlos González-Juanatey; Luis Rodriguez-Rodriguez; Miguel A González-Gay Journal: Arthritis Res Ther Date: 2018-08-29 Impact factor: 5.156